West Pharmaceutical Services Stock Price, News & Analysis (NYSE:WST)

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

West Pharmaceutical Services announced a quarterly dividend on Thursday, July 25th. Investors of record on Wednesday, October 23rd will be given a dividend of $0.15 per share on Wednesday, November 6th. This represents a $0.60 dividend on an annualized basis and a yield of 0.43%. The ex-dividend date is Tuesday, October 22nd. View West Pharmaceutical Services' Dividend History.

West Pharmaceutical Services declared that its board has initiated a share repurchase plan on Thursday, February 15th 2018, which allows the company to repurchase 800,000 shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its stock is undervalued.

West Pharmaceutical Services Inc. (NYSE:WST) announced its earnings results on Thursday, July, 25th. The medical instruments supplier reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.17. The medical instruments supplier had revenue of $469.70 million for the quarter, compared to analysts' expectations of $459.90 million. West Pharmaceutical Services had a return on equity of 16.93% and a net margin of 12.94%. The firm's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.70 EPS. View West Pharmaceutical Services' Earnings History.

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for West Pharmaceutical Services.

West Pharmaceutical Services will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

West Pharmaceutical Services issued an update on its FY19 earnings guidance on Thursday, July, 25th. The company provided EPS guidance of $3.00-3.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.89. The company issued revenue guidance of $1.810-1.825 billion, compared to the consensus revenue estimate of $1.81 billion.

3 equities research analysts have issued 12-month price objectives for West Pharmaceutical Services' shares. Their predictions range from $112.16 to $122.00. On average, they expect West Pharmaceutical Services' stock price to reach $117.08 in the next twelve months. This suggests that the stock has a possible downside of 16.4%. View Analyst Price Targets for West Pharmaceutical Services.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Media headlines about WST stock have trended somewhat positive on Monday, InfoTrie reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. West Pharmaceutical Services earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for West Pharmaceutical Services.

Some companies that are related to West Pharmaceutical Services include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), Neogen (NEOG), ICU Medical (ICUI), Quidel (QDEL), Merit Medical Systems (MMSI), Atrion (ATRI), STAAR Surgical (STAA), Anika Therapeutics (ANIK), Cerus (CERS), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include Mcdonald's (MCD), Johnson & Johnson (JNJ), Nike (NKE), Stanley Black & Decker (SWK), PepsiCo (PEP), Lowe's Companies (LOW), Medtronic (MDT), AFLAC (AFL), Sherwin-Williams (SHW) and NVIDIA (NVDA).

West Pharmaceutical Services' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (0.80%), Envestnet Asset Management Inc. (0.20%), Nisa Investment Advisors LLC (0.12%), McCollum Christoferson Group LLC (0.10%), Kistler Tiffany Companies LLC (0.07%) and Whittier Trust Co. (0.04%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

WST stock was sold by a variety of institutional investors in the last quarter, including First Citizens Bank & Trust Co., Pacer Advisors Inc., McCollum Christoferson Group LLC, Brinker Capital Inc., Brookstone Capital Management, Oakbrook Investments LLC, Financial Gravity Wealth Inc. and Crossmark Global Holdings Inc.. View Insider Buying and Selling for West Pharmaceutical Services.

WST stock was purchased by a variety of institutional investors in the last quarter, including Kistler Tiffany Companies LLC, Tuttle Tactical Management, Riverbridge Partners LLC, Robeco Institutional Asset Management B.V., Nisa Investment Advisors LLC, Fox Run Management L.L.C., State of Alaska Department of Revenue and Summit Creek Advisors LLC. View Insider Buying and Selling for West Pharmaceutical Services.

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WST stock can currently be purchased for approximately $140.08.

West Pharmaceutical Services has a market capitalization of $10.33 billion and generates $1.72 billion in revenue each year. The medical instruments supplier earns $206.90 million in net income (profit) each year or $2.81 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]